Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Increased hippocampal activation in ApoE-4 carriers and non-carriers with amnestic mild cognitive impairment.

Tran TT, Speck CL, Pisupati A, Gallagher M, Bakker A.

Neuroimage Clin. 2016 Dec 7;13:237-245. doi: 10.1016/j.nicl.2016.12.002. eCollection 2017.

2.

Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression.

Huijbers W, Mormino EC, Schultz AP, Wigman S, Ward AM, Larvie M, Amariglio RE, Marshall GA, Rentz DM, Johnson KA, Sperling RA.

Brain. 2015 Apr;138(Pt 4):1023-35. doi: 10.1093/brain/awv007. Epub 2015 Feb 11.

3.

Posteromedial hyperactivation during episodic recognition among people with memory decline: findings from the WRAP study.

Nicholas CR, Okonkwo OC, Bendlin BB, Oh JM, Asthana S, Rowley HA, Hermann B, Sager MA, Johnson SC.

Brain Imaging Behav. 2015 Dec;9(4):690-702. doi: 10.1007/s11682-014-9322-z.

4.

P301L tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathway.

Hunsberger HC, Rudy CC, Batten SR, Gerhardt GA, Reed MN.

J Neurochem. 2015 Jan;132(2):169-82. doi: 10.1111/jnc.12967. Epub 2014 Oct 31.

5.

A systematic review of type 2 diabetes mellitus and hypertension in imaging studies of cognitive aging: time to establish new norms.

Meusel LA, Kansal N, Tchistiakova E, Yuen W, MacIntosh BJ, Greenwood CE, Anderson ND.

Front Aging Neurosci. 2014 Jul 8;6:148. doi: 10.3389/fnagi.2014.00148. eCollection 2014. Review.

6.

White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's disease.

Adluru N, Destiche DJ, Lu SY, Doran ST, Birdsill AC, Melah KE, Okonkwo OC, Alexander AL, Dowling NM, Johnson SC, Sager MA, Bendlin BB.

Neuroimage Clin. 2014 Apr 21;4:730-42. doi: 10.1016/j.nicl.2014.04.008. eCollection 2014.

7.

Effects of apolipoprotein E genotype on the off-line memory consolidation.

Wang DY, Han XJ, Li SF, Liu DQ, Yan CG, Zuo XN, Zhu CZ, He Y, Kiviniemi V, Zang YF.

PLoS One. 2012;7(12):e51617. doi: 10.1371/journal.pone.0051617. Epub 2012 Dec 12.

8.

Comparison of semantic and episodic memory BOLD fMRI activation in predicting cognitive decline in older adults.

Hantke N, Nielson KA, Woodard JL, Breting LM, Butts A, Seidenberg M, Carson Smith J, Durgerian S, Lancaster M, Matthews M, Sugarman MA, Rao SM.

J Int Neuropsychol Soc. 2013 Jan;19(1):11-21. doi: 10.1017/S1355617712000951. Epub 2012 Nov 30.

9.

Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study.

O'Dwyer L, Lamberton F, Matura S, Tanner C, Scheibe M, Miller J, Rujescu D, Prvulovic D, Hampel H.

PLoS One. 2012;7(11):e48895. doi: 10.1371/journal.pone.0048895. Epub 2012 Nov 9.

10.

The cognitive neuroscience of ageing.

Grady C.

Nat Rev Neurosci. 2012 Jun 20;13(7):491-505. doi: 10.1038/nrn3256. Review.

11.

Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment.

Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, Yassa MA, Bassett SS, Shelton AL, Gallagher M.

Neuron. 2012 May 10;74(3):467-74. doi: 10.1016/j.neuron.2012.03.023.

12.

Family history and APOE-4 genetic risk in Alzheimer's disease.

Donix M, Small GW, Bookheimer SY.

Neuropsychol Rev. 2012 Sep;22(3):298-309. doi: 10.1007/s11065-012-9193-2. Epub 2012 Feb 23. Review.

13.

Episodic memory on the path to Alzheimer's disease.

Gallagher M, Koh MT.

Curr Opin Neurobiol. 2011 Dec;21(6):929-34. doi: 10.1016/j.conb.2011.10.021. Epub 2011 Nov 11. Review.

14.

Functional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease risk.

Sugarman MA, Woodard JL, Nielson KA, Seidenberg M, Smith JC, Durgerian S, Rao SM.

Biochim Biophys Acta. 2012 Mar;1822(3):442-56. doi: 10.1016/j.bbadis.2011.09.016. Epub 2011 Oct 4. Review.

15.

The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations.

Tuminello ER, Han SD.

Int J Alzheimers Dis. 2011 Feb 24;2011:726197. doi: 10.4061/2011/726197.

16.

Increased fMRI signal with age in familial Alzheimer's disease mutation carriers.

Braskie MN, Medina LD, Rodriguez-Agudelo Y, Geschwind DH, Macias-Islas MA, Cummings JL, Bookheimer SY, Ringman JM.

Neurobiol Aging. 2012 Feb;33(2):424.e11-21. doi: 10.1016/j.neurobiolaging.2010.09.028. Epub 2010 Dec 3.

17.

Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults.

Ward MA, Bendlin BB, McLaren DG, Hess TM, Gallagher CL, Kastman EK, Rowley HA, Asthana S, Carlsson CM, Sager MA, Johnson SC.

Front Aging Neurosci. 2010 Jul 15;2. pii: 29. doi: 10.3389/fnagi.2010.00029. eCollection 2010.

18.

White matter in aging and cognition: a cross-sectional study of microstructure in adults aged eighteen to eighty-three.

Bendlin BB, Fitzgerald ME, Ries ML, Xu G, Kastman EK, Thiel BW, Rowley HA, Lazar M, Alexander AL, Johnson SC.

Dev Neuropsychol. 2010;35(3):257-77. doi: 10.1080/87565641003696775.

19.

Increased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease.

Wierenga CE, Stricker NH, McCauley A, Simmons A, Jak AJ, Chang YL, Delano-Wood L, Bangen KJ, Salmon DP, Bondi MW.

Neuroimage. 2010 Jul 1;51(3):1222-33. doi: 10.1016/j.neuroimage.2010.03.021. Epub 2010 Mar 16.

20.

Midlife predictors of Alzheimer's disease.

Bendlin BB, Carlsson CM, Gleason CE, Johnson SC, Sodhi A, Gallagher CL, Puglielli L, Engelman CD, Ries ML, Xu G, Wharton W, Asthana S.

Maturitas. 2010 Feb;65(2):131-7. doi: 10.1016/j.maturitas.2009.12.014. Epub 2009 Dec 30. Review.

Supplemental Content

Support Center